Abstract:Purpose: The association between high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) and cardiovascular risk in patients with coronary artery disease remains inconsistent. Recent investigations indicated potential dysfunctionality of HDL under inflammation. This study endeavors to explore whether the inflammatory status modifies the effects of HDL-C and ApoA-I on cardiovascular risk in individuals with percutaneous coronary intervention (PCI). Patients and methods: Consecutive 10,724 PCI patients at Fuwai hospital in 2013 were enrolled. Inflammation status was defined by high-sensitivity C-reactive proteins (hsCRP) ≥ 2 mg/L. The study endpoint was cardiac mortality. Results: Among 9569 PCI patients eventually included, 225 (2.4%) cardiac mortality happened during 5 years. In hsCRP ≥ 2 mg/L group, an U-shaped curve was observed for HDL-C and multivariate Cox regression showed that elevated risks of cardiac mortality correlated to both the lowest quintile (hazard ratio [HR], 2.50; 95% confidence interval [CI], 1.32-4.71) and the highest quintile of HDL-C (HR, 2.28; 95% CI, 1.23-4.25). However, an L-shaped curve existed in ApoA-I, indicating only the lowest quintile level of ApoA-I was associated with an increased cardiac mortality risk (HR, 2.19; 95% CI, 1.28-3.75). Nevertheless, in hsCRP < 2 mg/L group, no significant correlations between HDL-C and ApoA-I and cardiac mortality risk were identified (both P > 0.05). Conclusion: In PCI patients with hsCRP ≥ 2 mg/L. both low and high HDL-C levels correlated with higher cardiac mortality risk (U-shaped), while only low ApoA-I levels were linked to elevated risk (L-shaped). However, in patients with hsCRP < 2 mg/L, neither HDL-C nor ApoA-I levels were associated with higher cardiac mortality risk. These findings shed light on the importance of considering inflammation status, particularly hsCRP levels, in managing HDL-C and ApoA-I levels, and suggest targeting elevated ApoA-I levels as a potential therapeutic approach for PCI patients with hsCRP ≥ 2 mg/L.

The influence of RICP on levels of apelin in obesity AMI patients following PCI treatment

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

Influence of Serum Apelin and CD40L Expression Levels on Adverse Cardiovascular Events after PCI

Elevated High Sensitive C-reactive Protein and Apelin Levels after Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation

Influence of intracoronary tirofiban application on coronary blood flow,endothelial function and in-flammatory factors in AMI patients

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Effect of PCI on plasma ADMA and hs-CRP in unstable angina pectoris patients during perioperative period

Serum Apelin Level Predicts The Major Adverse Cardiac Events In Patients With St Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention

Major cardiovascular events and readmission risk of patients post percutaneous coronary intervention in one year based on ApoB/ApoA-Ι

Associations of HDL-C and ApoA-I with Mortality Risk in PCI Patients Across Different hsCRP Levels

Negative association of apelin plasma levels with epicardial fat thickness in patients with stable angina and acute myocardial infarction: A case-control study

Intensive atorvastatin therapy decreases plasma hs-CRP and increases plasma adiponectin in patients undergoing elective percutaneous coronary intervention

Effect of Facilitated Percutaneous Coronary Intervention on Plasma Brain Natriuretic Peptide Levels and Left Ventricular Remodeling in Patients with Acute Myocardial Infarction

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Prophylactic Intra-Aortic Balloon Pump Reduces C-Reactive Protein Levels And Early Mortality In High-Risk Patients Undergoing Percutaneous Coronary Intervention

Circulating Lipid and Lipoprotein Profiles and Their Correlation to Cardiac Function and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction

The Effect of Percutaneous Coronary Intervention on the Activities of Peripheral Blood Monocytes and Inflammation in Patients with Stable Angina Pectoris

Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China

Effects of individualized health education and follow-up on risk factors among patients with acute myocardial infarction after percutaneous coronary intervention

The Change and Signficance of High-Sensitivity C-reactive Protein Level in Different Therapies for Patients with Acute Myocardial Infarction

The Influence of Emergency Percutaneous Coronary Intervention on Plasma Cytokines in Acute Myocardial Infarction